Rare Disease, Alexion and Merck (MRK) announced positive topline results from the Phase 3 KOMET trial, a Phase 3 trial in ...

Merck KGaA (MKGAY.PK), a German science and technology major, announced that the Phase III MANEUVER trial of pimicotinib, an ...

Rahway, New Jersey Wednesday, November 13, 2024, 13:00 Hrs [IST] ...

First Lady Monica Chakwera and other African First Ladies have commended Merck Foundation for various activities it is ...

She previously served as Chief Executive Officer at Harpoon Therapeutics until the company’s acquisition by Merck in early 2024. In addition to Ms. Eastland’s appointment, Ingmar Bruns, M.D., has been ...

This adoption underscores TileDB's foundational role in advancing precision medicine through drug discovery pipelines ... Prior to joining Alexion in 2015, George was employed by Merck & Co., Inc. for ...

The Children’s Inn at the National Institutes of Health is breaking ground on a project that will allow the nonprofit to ...

Nov. 13, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company ...

“Bruce had a brilliant career in both academia and industry and left an indelible mark on the Alzheimer’s disease drug development landscape,” noted Robert Vassar, Northwestern University, Chicago ...

The Children’s Inn at NIH, a private nonprofit that supports kids in clinical trials, just broke ground on a long-planned ...